Flagship Pioneering commits £100 million to build AI-driven drug companies in Britain
This story is from 2026-11-16. It is preserved in the archive; the latest stories are on the live feed.
Flagship Pioneering is opening its first company-creation lab outside the United States in the UK, committing £100 million ($131.94 million) to fund and build AI-driven biotech companies.
Read the full story at Reuters AI ↗
Timeline · 1 report
- 2026-11-16 20:10 · Reuters AI
Venture firm Flagship bets £100 million to build AI-driven drug companies in Britain